Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 6/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 8/20 | 0.37 |
| ▸ | FNTB | P49356 | 6/20 | 0.37 |
| ▸ | PGGT1B | P53609 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27665113 | 0.95 | BTN3A1 (0.39) | BTN3A1LPAR2LPAR3FDPSBLM | |
| SCHEMBL11335633 | 0.88 | BTN3A1 (0.35) | BTN3A1LPAR2LPAR3FDPSBLM | |
| SCHEMBL7196957 | 0.88 | BTN3A1 (0.35) | BTN3A1LPAR2LPAR3FDPSBLM | |
| SCHEMBL28997347 | 0.88 | BTN3A1 (0.43) | BTN3A1LPAR2LPAR3FNTAFNTB | |
| SCHEMBL31618784 | 0.87 | BTN3A1 (0.61) | BTN3A1FNTAFNTBPGGT1B | |
| Ammonia Solution, Strong SCHEMBL29111943 | 0.86 | BTN3A1 (0.38) | BTN3A1LPAR2LPAR3FDPSBLM | |
| SCHEMBL6695477 | 0.86 | BTN3A1 (0.42) | BTN3A1LPAR2LPAR3FDPSBLM | |
| SCHEMBL1075958 | 0.85 | LPAR2 (0.31) | LPAR2LPAR3 | |
| SCHEMBL28944063 | 0.83 | BTN3A1 (0.40) | BTN3A1LPAR2LPAR3FDPSBLM | |
| Allyl Pyrophosphate SCHEMBL1075959 | 0.82 | BTN3A1 (0.59) | BTN3A1FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116838044-A | Floor or wallboard and method for producing same | 财纳福诺木业(中国)有限公司 | 2023-10-03 | — | — | CN | claimed |
| US-10208195-B2 | Polypropylene resin composition and cable cladded with the same | LG CHEM, LTD. (KR) | 2019-02-19 | — | — | US | claimed |
| EP-3178881-B1 | POLYPROPYLENE RESIN COMPOSITION AND CABLE COATED WITH SAME | LG CHEMICAL LTD (KR) | 2018-12-19 | — | — | EP | claimed |
| US-20170292015-A1 | POLYPROPYLENE RESIN COMPOSITION AND CABLE CLADDED WITH THE SAME | LG CHEM, LTD. (KR) | 2017-10-12 | — | — | US | claimed |
| EP-3178881-A1 | POLYPROPYLENE RESIN COMPOSITION AND CABLE COATED WITH SAME | LG Chem, Ltd. (KR) | 2017-06-14 | — | — | EP | claimed |
| EP-0011516-B1 | PROCESS FOR THE RECUPERATION OF URANIUM PRESENT IN PHOSPHATIC COMPOUNDS | COMPAGNIE FRANCAISE DE MOTKA (FR) | 1983-09-28 | — | — | EP | claimed |
| CN-116838044-A | Floor or wallboard and method for producing same | 财纳福诺木业(中国)有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20230041342-A1 | ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY | Microvascular Therapeutics LLC (US) | 2023-02-09 | — | — | US | disclosed |
| EP-4087929-A1 | ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY | Microvascular Therapeutics LLC (US) | 2022-11-16 | — | — | EP | disclosed |
| CN-109713367-B | Silicon-containing high-energy-density lithium ion battery | 安普瑞斯（南京）有限公司 | 2022-02-22 | — | — | CN | disclosed |
| WO-2021142059-A1 | ALKYLATED NUCLEOSIDES, AND COMPOSITIONS AND METHODS THEREOF FOR NUCLEIC ACID DELIVERY | MICROVASCULAR THERAPEUTICS, LLC (US) | 2021-07-15 | — | — | WO | disclosed |
| CN-110157749-B | Method for synthesizing MK-7 by using bacillus subtilis group response regulation and control system | 江南大学 | 2020-10-09 | — | — | CN | disclosed |
| US-10208195-B2 | Polypropylene resin composition and cable cladded with the same | LG CHEM, LTD. (KR) | 2019-02-19 | — | — | US | disclosed |
| US-20140117570-A1 | METHOD OF PRODUCING AN OPTICAL COMPENSATION FILM | FUJIFILM CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-20140111745-A1 | ACRYL-BASE POLYMER FILM, OPTICAL COMPENSATION FILM, AND LIQUID-CRYSTAL DISPLAY DEVICE HAVING THE SAME | FUJIFILM CORPORATION (JP) | 2014-04-24 | — | — | US | disclosed |
| US-8654287-B2 | Acryl-base polymer film, optical compensation film, and liquid-crystal display device having the same | FUJIFILM CORPORATION (JP) | 2014-02-18 | — | — | US | disclosed |
| US-20100245725-A1 | ACRYL-BASE POLYMER FILM, OPTICAL COMPENSATION FILM, AND LIQUID-CRYSTAL DISPLAY DEVICE HAVING THE SAME | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100040806-A1 | CELLULOSE ESTER OPTICAL FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY USING THE CELLULOSE ESTER OPTICAL FILM, AND METHOD FOR PRODUCING CELLULOSE ESTER OPTICAL FILM | KONICA MINOLTA OPTO, INC. (JP) | 2010-02-18 | — | — | US | disclosed |
| US-20080057227-A1 | Manufacturing method of cellulose acylate film, cellulose acylate film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-0011516-A1 | Process for the recuperation of uranium present in phosphatic compounds | COMPAGNIE FRANCAISE DE MOTKA (FR) | 1980-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100245725-A1 | ACRYL-BASE POLYMER FILM, OPTICAL COMPENSATION FILM, AND LIQUID-CRYSTAL DISPLAY DEVICE HAVING THE SAME | CFH, RPP30, BLM | BTN3A1 2637/4885LPAR2 2539/4885LPAR3 1971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.